This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Acute Angle-Closure Glaucoma and Paroxetine

Catherine F. Lewis, John R. DeQuardo, Charles DuBose, and Rajiv Tandon

Published: March 15, 1997

Article Abstract

Letter to the Editor

Sir: Acute angle-closure glaucoma has been linked to use of
tricyclic antidepressants and monoamine oxidase inhibitors.
Susceptible patients are described as those with a history of
angle-closure, age greater than 40 years, dilated pupils at initial
examination, a personal or family history of glaucoma, and a
history of ocular symptoms (visual abnormalities and/or eye
pain). While there is some debate about the role of antidepressant
medication in exacerbating or causing glaucoma, clinicians
have advocated use of serotonin selective reuptake inhibitors (SSRIs) in treatment of high-risk patients. We report a case of
acute angle-closure glaucoma related to paroxetine use in a patient
with mydriasis on examination prior to treatment but who
had no personal or family history of glaucoma.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 58

Quick Links: